149 related articles for article (PubMed ID: 18024643)
41. [Non-Hodgkin lymphoma: Excellent results at the expense of the high toxicity of the treatment].
Baena-Gómez MA; Mora Matilla M; Lassaletta Atienza A; Andión Catalán M; Hernández Marqués C; Madero López L
An Pediatr (Barc); 2015 Jun; 82(6):381-7. PubMed ID: 25446790
[TBL] [Abstract][Full Text] [Related]
42. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
[TBL] [Abstract][Full Text] [Related]
43. B-NHL Cases in a Tertiary Pediatric Hematology-Oncology Department: A 20-Year Retrospective Cohort Study.
Kyriakidis I; Pelagiadis I; Stratigaki M; Katzilakis N; Stiakaki E
Life (Basel); 2024 May; 14(5):. PubMed ID: 38792653
[TBL] [Abstract][Full Text] [Related]
44. Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies.
Egan G; Goldman S; Alexander S
Br J Haematol; 2019 Jun; 185(6):1071-1085. PubMed ID: 30613948
[TBL] [Abstract][Full Text] [Related]
45. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
[TBL] [Abstract][Full Text] [Related]
46. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.
Meinhardt A; Burkhardt B; Zimmermann M; Borkhardt A; Kontny U; Klingebiel T; Berthold F; Janka-Schaub G; Klein C; Kabickova E; Klapper W; Attarbaschi A; Schrappe M; Reiter A;
J Clin Oncol; 2010 Jul; 28(19):3115-21. PubMed ID: 20516455
[TBL] [Abstract][Full Text] [Related]
47. [Malignant lymphoma of adolescents and young adults: from the viewpoint of pediatricians].
Kobayashi R; Sekimizu M
Rinsho Ketsueki; 2017; 58(8):1053-1059. PubMed ID: 28883269
[TBL] [Abstract][Full Text] [Related]
48. Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report.
Miles RR; Cairo MS; Satwani P; Zwick DL; Lones MA; Sposto R; Abromovitch M; Tripp S; Angiolillo AL; Roman E; Davenport V; Perkins SL
Br J Haematol; 2007 Aug; 138(4):506-12. PubMed ID: 17659054
[TBL] [Abstract][Full Text] [Related]
49. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
50. Lymphoma subtype incidence rates in children and adolescents: first report from Brazil.
Ferreira JM; Klumb CE; de Souza Reis R; de Oliveira Santos M; Oliveira JF; de Camargo B; Pombo-de-Oliveira MS
Cancer Epidemiol; 2012 Aug; 36(4):e221-6. PubMed ID: 22552334
[TBL] [Abstract][Full Text] [Related]
51. Revised International Pediatric Non-Hodgkin Lymphoma Staging System.
Rosolen A; Perkins SL; Pinkerton CR; Guillerman RP; Sandlund JT; Patte C; Reiter A; Cairo MS
J Clin Oncol; 2015 Jun; 33(18):2112-8. PubMed ID: 25940716
[TBL] [Abstract][Full Text] [Related]
52. [Cytogenetic study on 155 cases of non-Hodgkin' s lymphoma].
Wang XQ;
Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):656-60. PubMed ID: 17343195
[TBL] [Abstract][Full Text] [Related]
53. Imaging of pediatric lymphomas.
Abramson SJ; Price AP
Radiol Clin North Am; 2008 Mar; 46(2):313-38, ix. PubMed ID: 18619383
[TBL] [Abstract][Full Text] [Related]
54. Paediatric lymphoma in China: a clinicopathological study of 213 cases.
Wang J; Wu X; Shen Y; Xi Z
Pathology; 2012 Dec; 44(7):622-5. PubMed ID: 23149377
[TBL] [Abstract][Full Text] [Related]
55. Role of interferon-alfa in NHL: still controversial?
Haase-Statz S; Smalley RV
Oncology (Williston Park); 1999 Aug; 13(8):1147-59; discussion 1159-60, 1163. PubMed ID: 10499247
[TBL] [Abstract][Full Text] [Related]
56. [Outcome of children and adolescents with Burkitt lymphoma and diffuse large B cell lymphoma treated with a modified NHL-BFM-90 protocol].
Sun XF; Zhen ZJ; Xia Y; Lin SX; Zhu J; Wang J; Lu SY; Sun FF; Chen Y; Zhang F; Cai RQ; Li PF
Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1032-7. PubMed ID: 24369160
[TBL] [Abstract][Full Text] [Related]
57. Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials.
Seidemann K; Henze G; Beck JD; Sauerbrey A; Kühl J; Mann G; Reiter A
Ann Oncol; 2000; 11 Suppl 1():141-5. PubMed ID: 10707797
[TBL] [Abstract][Full Text] [Related]
58. Frequency and clinicopathologic correlation of different types of non Hodgkin's lymphoma according to WHO classification.
Naz E; Mirza T; Aziz S; Danish F; Siddiqui ST; Ali A
J Pak Med Assoc; 2011 Mar; 61(3):260-3. PubMed ID: 21465941
[TBL] [Abstract][Full Text] [Related]
59. [Malignant lymphoma in adolescents and young adults: from the viewpoint of physicians].
Maruyama D
Rinsho Ketsueki; 2017; 58(8):1060-1068. PubMed ID: 28883270
[TBL] [Abstract][Full Text] [Related]
60. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
